These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11840984)

  • 21. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
    Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
    Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
    Levi M; Peters M; Büller HR
    Crit Care Med; 2005 Apr; 33(4):883-90. PubMed ID: 15818119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.
    Al Hammadi AM; Sallah S
    J Thromb Haemost; 2007 Feb; 5(2):435-6. PubMed ID: 17269940
    [No Abstract]   [Full Text] [Related]  

  • 24. Coagulation management in massive bleeding.
    Griffee MJ; Deloughery TG; Thorborg PA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
    Holcomb JB; Hoots K; Moore FA
    Mil Med; 2005 Apr; 170(4):287-90. PubMed ID: 15916295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ongoing NovoSeven trials.
    Erhardtsen E
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant factor VIIa and the surgical patient.
    Scarpelini S; Rizoli S
    Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring coagulation and the clinical effects of recombinant factor VIIa.
    Gabriel DA; Carr M; Roberts HR
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):20-4. PubMed ID: 14872416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of recombinant factor VIIa in infants with severe coagulopathy.
    Fontaine MJ; Lazarchick J; Taylor S; Annibale D
    J Perinatol; 2004 May; 24(5):310-1. PubMed ID: 15116125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
    Poon MC; d'Oiron R
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S55-68. PubMed ID: 10850567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant factor VIIa: how safe is the stuff?
    Roberts HR
    Can J Anaesth; 2005 Jan; 52(1):8-11. PubMed ID: 15625249
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation problems in liver disease.
    Rapaport SI
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S69-74. PubMed ID: 10850568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novoseven use in a non-cardiac pediatric ECMO patient with uncontrolled bleeding.
    Preston TJ; Olshove VF; Ayad O; Nicol KK; Riley JB
    J Extra Corpor Technol; 2008 Jun; 40(2):123-6. PubMed ID: 18705548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant factor VIIa and trauma: treatment that does not leave you in the cold.
    Levi M
    J Thromb Haemost; 2007 Feb; 5(2):242-3. PubMed ID: 17181827
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of bleeding using recombinant factor VIIa in a patient suffering from bleeding tendency due to a lupus anticoagulant-hypoprothrombinemia syndrome.
    Holm M; Andreasen R; Ingerslev J
    Thromb Haemost; 1999 Dec; 82(6):1776-8. PubMed ID: 10613675
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence-based haemostasis. Proceedings of a symposium. Dublin, Ireland. November 9-11, 2001.
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():V; 1-52. PubMed ID: 12803171
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma.
    Van Der Schueren B; Hammer F; Verschuren F; Hantson P; Deneys V; Hermans C
    Thromb Haemost; 2005 Dec; 94(6):1327-8. PubMed ID: 16411413
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
    Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
    Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.